Announcements Trials
Browse Landscape

Phase

Phase 1/2 2Phase 2 1

Status

Terminated 2Completed 1

Sponsor Class

OTHER 3NIH 2

Study Type

Interventional 3

Sponsor

Cancer Type

Dermatologic 2Breast 1

Conditions

Leukemia, Myeloid, Acute 132Myelodysplastic Syndromes 57Leukemia 32Leukemia, Myelomonocytic, Chronic 23Recurrence 18Lymphoma, Large B-Cell, Diffuse 10Myeloproliferative Disorders 9Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Neoplasms 8Congenital Abnormalities 7Primary Myelofibrosis 6Melanoma 6Hodgkin Disease 6Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5Ovarian Neoplasms 5Blast Crisis 5Thrombocythemia, Essential 4Polycythemia Vera 4Myelodysplastic-Myeloproliferative Diseases 4Lymphoma 4Leukemia, Monocytic, Acute 4Leukemia, Biphenotypic, Acute 4Anemia, Refractory, with Excess of Blasts 4Neoplasm Metastasis 3Leukemia, Myelomonocytic, Acute 3Leukemia, Myeloid, Accelerated Phase 3Head and Neck Neoplasms 3Fallopian Tube Neoplasms 3Breast Neoplasms 3Triple Negative Breast Neoplasms 2

Interventions

Radiosurgery 79Capecitabine 77Oxaliplatin 74Fluorouracil 69Bevacizumab 69Gemcitabine 67Leucovorin 61pembrolizumab 53Nivolumab 53Paclitaxel 48Irinotecan 47Radiotherapy 45Cisplatin 44Everolimus 38Magnetic Resonance Spectroscopy 36Drug Therapy 36Docetaxel 36Cyclophosphamide 35Cetuximab 35Ipilimumab 32Carboplatin 32Trastuzumab 31Sunitinib 30Sorafenib 26Erlotinib Hydrochloride 25Doxorubicin 23Surveys and Questionnaires 20Surgical Procedures, Operative 20Specimen Handling 20Biopsy 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Neoplasm Metastasis × Decitabine × Clear all
NCT03295552 2022-04-06

DETECT

Shanghai Jiao Tong University School of Medicine

Phase 2 Terminated
12 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis, Triple Negative Breast Neoplasms

NCT00715793 2017-10-03

UPCI-07-008

University of Pittsburgh

Phase 1/2 Completed
39 enrolled 12 charts
Dermatologic

Melanoma, Neoplasm Metastasis, Skin Neoplasms

NCT00925132 2017-07-02

Treatment of Resistant Metastatic Melanoma Using Decitabine, Temozolomide and Panobinostat

University of Iowa

Phase 1/2 Terminated
39 enrolled 8 charts
Dermatologic

Melanoma, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡